HowardC.S., TeitelbaumI.Renal replacement therapy in patients with chronic liver disease.Semin Dial2005; 18: 212–16.
2.
ArbeiterA.K., KranzB., WingenA.M., BonzelK.E., Dohna-SchwakeC., HansslerL.Continuous venovenous haemodialysis (CVVHD) and continuous peritoneal dialysis (CPD) in the acute management of 21 children with inborn errors of metabolism.Nephrol Dial Transplant2010; 25: 1257–65.
3.
BatshawM.L., BrusilowS.W.Treatment of hyperammonemic coma caused by inborn errors of urea synthesis.J Pediatr1980; 97: 893–900.
4.
SelgasR., BajoM.A., Del PesoG., Sánchez-VillanuevaR., GonzalezE., RomeroS.Peritoneal dialysis in the comprehensive management of end-stage renal disease patients with liver cirrhosis and ascites: practical aspects and review of the literature.Pent Dial Int2008; 28: 118–22.
5.
AfsarB., ElsurerR., BilgicA., SezerS., OzdemirF.Regular lactulose use is associated with lower peritonitis rates: an observational study.Perit Dial Int2010; 30: 243–6.
6.
ChaudharyK., KhannaR.Renal replacement therapy in end-stage renal disease patients with chronic liver disease and ascites: role of peritoneal dialysis.Perit Dial Int2008; 28: 113–17.
TaraoK., SoK., MoroiT., IkeuchiT., SuyamaT.Detection of endotoxin in plasma and ascitic fluid of patients with cirrhosis: its clinical significance.Gastroenterology1977; 73: 539–42.
